6.1. KESIMPULAN
Sepsis neonatorum merupakan penyebab utama mortalitas dan morbiditas pada neonatus. Baku emas untuk menegakkan diagnosis sepsis adalah kultur darah namun membutuhkan waktu 3 sampai 5 hari dan biaya yang tidak murah untuk memperoleh hasilnya, sehingga terjadi keterlambatan pengobatan yang dapat memperburuk keadaan bayi bahkan bisa menyebabkan kematian. Diperlukan suatu cara yang cepat dan tepat untuk menegakkan diagnosis dini sepsis bakterialis pada neonatus. Pada penelitian didapatkan bahwa Prokalsitonin merupakan suatu cara yang cepat dan tepat untuk menegakkan diagnosis dini sepsis bakterialis pada neonatus.
6.2. SARAN
Perlu dilakukan penelitian terutama dengan sampel bayi baru lahir untuk menilai sepsis pada tahap awal sebelum terpapar dengan pemakaian antibiotik. Oleh karena pola resistensi antibiotik berubah sejalan dengan pemakaian antibiotik yang tidak tepat maka perlu dilakukan penelitian lanjutan tentang pola kuman dan pola resistensi antibiotik terhadap kuman penyebab sepsis bakterialis pada neonatus di Rumah Sakit Umum Pusat Haji Adam Malik Medan.
DAFTAR PUSTAKA
1. Amirullah A. Sepsis pada bayi baru lahir. Dalam: Kasim SM, Yunanto A, Dewi R, Sarosa IG, Usman A, penyunting. Buku ajar neonatologi. Jakarta: Ikatan Dokter Anak Indonesia; 2008. h. 170-87
2. Gomella TL, Cuningham MD, Eyal FG, Zenk KE. Infectious Disease. Dalam: Gomella TL, Cuningham MD, Eyal FG, Zenk KE, penyunting. Management, procedures, on-call problems, disease and drugs. New York: Mc Graw-Hill; 2007. h. 434-40
3. Polin RA, Parravicini E, Regan JA, Taeusch HW. Bacterial sepsis and meningitis. Dalam: Taeusch HW, Ballard RA, Gleason CA, penyunting. Avery’s diseases of the newborn. Edisi ke-8. Philadelphia; Elsevier Saunders;2005. h. 551-600
4. Klinger G, Levy I, Sirota L, Boyko V, Geva LL, Reichman B. outcome of early onset sepsis in neonatal cohort of very lowbirth weight infants. Pediatrics. 2010;125: e736-40
5. Jackson GL, Engle WD, Sendelbach DM, Vedro DA, Josey S, Vinson J. Are complete blood cell count useful in the evaluation of asymptomatic neonates exposed to suspected chorioamnitis. Pediatrics. 2004;113:1173-80
6. Stoll BJ. Infections of the neonatal. Dalam: Behrman RE, Kiegman RM, Jenson HB, Stanton BF, penyunting. Nelson textbook of pediatrics. Edisi 18. Philadelphia: Saunders Company; 2007. h. 794-811
7. Dear P. Infection in newborn. Dalam: Rennie JM, penyunting. Roberton’s textbook of neonatology. Edisi ke-4. Elsevier Chrchill Livingstone; 2005. h. 1011-91
8. Bender L, thaarup J, Varming K, Krarup H, Eriksen SE, Ebbesen F. Early and late markers for detection of early onset neonatal sepsis. Dan Med Bull. 2008;55:219-23
9. Rodwell TE, Leslie AL, Tudehope DL. Early diagnosis of neonatal sepsis. J Pediatr. 2008;112:761-7
10. Hall R, Domenico H, Self W, hain P. Reducing the blood culture contamination rate in a pediatric emergency department and subsequent cost savings. Pediatrics. 2013; 131: e292-7
11. Arai T, Kumasaka K, Nagata K, Okita T, Oomura T, Hoshiai A et al. Prediction of blood culture results by measuring procalcitonin levels and other inflammatory biomarkers. American J of Emergency Medicine. 2014;32:330-3
12. Chan YL, Tseng CP, Tsay PK, Chang SS, Chiu TF, Chen JC. Procalcitonin as a marker of bacterial infection in the emergency department: an observational study. Crit Care Med. 2003; 8:R12-R20 13. Henriquez C, Losa J. Biomarkers for sepsis, Review article. Biomed
14. Faesch S, Cojocaru B, Hennequin C, Pannier S, Glorion C, Locour . Can procalcitonin measurement help the diagnosis of osteomyelitis and septic arthritis?A prospective trial. Italian J Pediatr. 2009;35:1-6 15. Zahedpasha Y, Kacho MA, Hajiahmadi M, Haghshenas M.
Procalcitonin as a marker sepsis of neonatal sepsis. Iran J Pediatr. 2009; 19:117-22
16. Sakha K, Husseini MB, Seyyedsadri. The role of the procalcitonin in diagnosis of neonatal sepsis and correlation between procalcitonin and C-reactive protein in these patients. Pak J Biol Sci. 2008; 14:1785-90 17. Alzahrani AJ, Hassan MI, Obeid EO, Diab AE, Qutub HO, Gupta RK.
Rapid detection of procalcitonin as an early marker of sepsis in intensive care unit in tertiary hospital. Int J. Med Med. Sci. 2009; 11:516-22
18. Stocker M, Fontana M, Helou S, Wegscheider K, Berger T. Use of procalcitonin-guided decision-making to shorten antibiotic therapy in suspected neonatal early-onset sepsis:prospective randomized intervention trial. Neonatal. 2010;97:165-74
19. Saputri DA. Pengaruh pemberian steroid dosis rendah terhadap hitung neutrofil pada sepsis tahap awal. Skripsi untuk sarjana kedokteran. Fakultas kedokteran universitas Sebelas Maret. Surakarta. 2010
20. Lubis CP. Infeksi nosokomial pada neonatus. Bagian kesehatan anak fakultas kedokteran Universitas Sumatra Utara.2003
21. Rinawati R. Kontroversi diagnosis sepsis neonatorum. Dalam: Badriul H, Partini PT, Evita BI, penyunting. Update in neonatal infection. Pendidikan kedokteran berkelanjutan ilmu kesehatan anak XLVII. h. 32-43
22. Aminullah A. Masalah terkini sepsis neonatorum. Dalam: Aminullah A, penyunting. Update in neonatal infection. Departemen Ilmu kesehatan Anak FKUI-RSCM. 2005. h. 17-31
23. Baltimore RS, Huie SM, Meek JI, Schuchat A, O’Brien KL. Early onset neonatal sepsis in the era of group B streptococcal prevention. Pediatrics. 2009;108:1094-8
24. Haque KN. Definitions of bloodstream infection in the newborn. Pediatr Crit Care Med. 2005: 6:545-9
25. Data based hasil kultur darah divisi perinatologi RSHAM 2008-2010 26. Osrin D, Vergnano S, Costello A. Serious bacterial infections in
newborn infants in developing countries. Curr Opin Infect Dis. 2004;17:217-24
27. Wynn J, CornellTT, Wong HR, Shanley TP, Wheeler DS. The host response to sepsis and developmental impact. Pediatrics. 2010;125:1031-41
29. Bochud PY, Calandra T. Clinical review: science, medicine, and the future pathogenesis of sepsis: new concepts and implications for future treatment. BMJ. 2003;326:262-6
30. Puopolo KM. Bacterial sepsis and meningitis. Dalam: Cloherty JP, Eichenwald EC, Stark AR, penyunting. Manual of neonatal care. Edisi 6. Philadelphia:Lippincott Williams & Willkins;2008. h. 274-80
31. Cornel TT, WynnJ, Shanley TP, Wheeler DS, Wong RH. Mechanisms and regulation of the gene-expression response to sepsis. J Pediatr. 2010;125:12-48-58
32. Mayor LK, Gonzales QV, O’Sullivan MJ, Hartstein AI, Roger S, Tamayo RN. Comparison of early-onset neonatal sepsis caused by eschericia coli and group B streptococcus. American J of Obstet and Gynecol. 2005;3192:143-7
33. Darmawan I. Sepsis Neonatorum. Dalam: Iyan I, penyunting. Update on sepsis. Jakarta: Farmedia, 2008. h.25-43
34. Dear P. Infection in the newborn. Dalam: Rennie JM, penyunting. Roberton’s textbook of neonatology. Edisi ke-4. USA: Elsevier Churchill Livingstone, 2005. h.1011-92
35. Polin RA, Parravicini E, Regan JA, Taeusch HW. Bacterial sepsis and meningitis. Dalam: Taeusch HW, Ballard RA, Gleason CA, penyunting. Avery’s diseases of the newborn. Edisi ke 8. Philadelphia: Elsevier Saunders, 2004. h.551-600
36. Hotchkiss RS, Karl IE. The pathophysiology and treatment of sepsis. N Engl J Med. 2003; 348:138-50
37. Maniaci V, Dauber A, Weiss S, Nylen E, Becker KL, Bachur R. Procalcitonin in young febril infants for the detection of serious bacterial infections. J Pediatr. 2008; 122:701-10
38. Haque K. Management of bacterial infection in the newborn. J Arab Neonatal Forum. 2006; 3:41-5
39. Smith K, Bigham M. Biomarkers in Pediatric sepsis. The open inflammatory Journal. 2011; 4(Suppl 1-M4)24-30
40. Ratzinger F, Schuardt M, Eichbichler K, Tsirkinidau I, Bauer M, Haslacher H et al. Utility os sepsis biomarkers and the infection probability score to discriminate sepsis and systemic inflammatory response syndrome in standard care patients. Plos One. 2013; 8:1-9 41. Mishra UK, Jacobs SE, Doyle LW, Garland SM. Newer approaches to
diagnosis of early onset neonatal. Arch Dis Child Fetal Neonatal Ed. 2006; 91:F208-F212
42. Koksal N, Harmanci R, Cetin M, Hacimustafaoglu M. Role of procalcitonin and CRP in diagnosis and follow-up of neonatal
43. Viallon A, Guyomarch P, Tardy B, Robert F, Marjolllet O, Caricajo A. Decrease in serum procalcitonin levels over time during treatment of bacterial meningitis. Crit Care Med. 2005; 9:R344-R350
44. Sastre JBL, Solis DP, Serradilla VR, Colomer BF, Cotallo GDC, Castrillo GH. Evaluation of procalcitonin for diagnosis of neonatal sepsis of vertical transmission. BMC Pediatr. 2007; 7:1-9
45. Nafaa M, Makhoul B, Tobia A, Kaplan M, Aronson D, Azzam Z et al. Procalcitonin and interleukin 6 for predicting blood culture positivity in sepsis. American J of Emergency Medicine. 2014; 32: 448-51
46. Buchori, Prihatini. Diagnosis sepsis menggunakan prokalsitonin. Ind J Clin Path Med Lab. 2006; 12:131-7
47. Standar Operating Procedure. Instalasi Patologi Klinik RSUP.H.Adam Malik, April 2009
48. Pusponegoro HD, Wirya IW, Pudjiadi AH, Bisanto J, Zulkarnain. Uji Diagnostik. Dalam: Sastroasmoro S, Ismael S, penyunting. Dasar-dasar metodologi penelitian klinis. Edisi ke-3. Jakarta. Sagung Seto; 2008. h.193-216
49. Xavier XL, Vargas S, Guerra F, Coronado L. Aplication of new sepsis definition for evaluate outcomeof pediatric patient with severe systemic infection. J. pediatr. 2008: 14; 557-60
50. Vazzalwar R, Rodrigues EP, Puppala BL, Angst DB, Schweig L. Procalcitonin as a screening test for late-onset sepsis in preterm very low birth weight infants. J. of Pediatr. 2005; 25:397-402
51. Rey C, Arcos ML, Concha A. Procalcitonin as a diagnostic and prognostic marker in critically ill children. Eur J Pediatr. 2010; 4:62-5 52. Lopez FR, Jimenes AE, Tobon GC, Mote JD, Farias ON. Procalcitonin
(PCT), C reactive protein (CRP) and its correlation with severity in early sepsis. Clin. Rev. Opinions. 2011; 3:26-31
LAMPIRAN
1. PERKIRAAN BIAYA PENELITIAN
1. Bahan / perlengkapan : Rp. 10.000.000 2. Transportasi / Akomodasi : Rp. 2.000.000 3. Penyusunan / penggandaan : Rp. 2.000.000 4. Seminar hasil penelitian : Rp. 6.000.000 Jumlah : Rp. 20. 000.000 2. JADWAL PENELITIAN WAKTU KEGIATAN April 2014
Mei - Juni 2014 Juli 2014
Persiapan Pelaksanaan Penyusunan laporan Pengiriman Laporan